-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CvcToxgrSvBhnEnS1TRLrT4HeD5lAS2LbIiCVEuv3NRGr7YUkSPCa0h3kJfBsSKV xHrh/9ld8vTJDumFxo3I2A== 0001010412-07-000312.txt : 20071129 0001010412-07-000312.hdr.sgml : 20071129 20071129144328 ACCESSION NUMBER: 0001010412-07-000312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071127 FILED AS OF DATE: 20071129 DATE AS OF CHANGE: 20071129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGUINE CORP CENTRAL INDEX KEY: 0000926287 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954347608 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 EAST GREEN ST STREET 2: #11 CITY: PASADENA STATE: CA ZIP: 91105 BUSINESS PHONE: 8184050079 MAIL ADDRESS: STREET 1: 101 EAST GREEN ST STREET 2: STE 11 CITY: PASADENA STATE: CA ZIP: 91105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Drees Thomas C CENTRAL INDEX KEY: 0001305482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24480 FILM NUMBER: 071274436 BUSINESS ADDRESS: BUSINESS PHONE: 626-405-0079 MAIL ADDRESS: STREET 1: 101 EAST GREEN STREET, #11 CITY: PASADENA STATE: CA ZIP: 91105 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2007-11-27 0 0000926287 SANGUINE CORP SGNC 0001305482 Drees Thomas C 101 EAST GREEN STREET, #6 PASADENA CA 91105 1 1 1 0 President, CEO Common Stock 31639000 D Common Stock 8589133 I By the Drees Family Trust Options 0.035 2007-11-20 4 J 0 10000000 0.035 D 2007-11-20 2012-11-27 Common Stock 10000000 21639000 D Options 0.035 2007-11-20 4 J 0 10000000 0.035 D 2007-11-20 2012-11-27 Common Stock 10000000 11639000 D On November 20, 2007, Dr. Drees executed an Option Agreement with LKB Partners, LLC ("LKB") (the "Drees/LKB Option Agreement") pursuant to which he granted LKB an option to purchase 10,000,000 shares of the Company's common stock that are owned by him at a purchase price of $0.035 per share for a term of five (5) years, subject to the Company raising no less than $500,000 by March 31, 2008, through the efforts of LKB or its associates. Please see the Company's Current Report on file with the Securities and Exchange Commission dated November 21, 2007. On November 20, 2007, Dr. Drees executed an Option Agreement with Terra Silex Holdings, LLC ("Terra Silex") (the "Drees/Terra Silex Option Agreement") pursuant to which he granted Terra Silex an option to purchase 10,000,000 shares of the Company's common stock that are owned by him at a purchase price of $0.035 per share for a term of five (5) years, subject to the Company raising no less than $500,000 by March 31, 2008, through the efforts of Terra Silex, pursuant to the Drees/Terra Silex Option Agreement. Please see the Company's Current Report on file with the Securities and Exchange Commission dated November 21, 2007. The $500,000 condition referenced in notes (1) and (2) is one offering with a total of $500,000, $100,000 of which has already been raised. /s/Thomas C. Drees 2007-11-28 -----END PRIVACY-ENHANCED MESSAGE-----